Table II.
2021 Recommended Scope and Cutoffs for Tier I Drugs/Drug Classes (ng/mL) for Screening and Confirmation in Blood, Urine and Oral Fluid
| Blood | Urine | Oral fluid | ||||
|---|---|---|---|---|---|---|
| Drug | Screen | Confirm | Screen | Confirm | Screen | Confirm |
| DRE category; cannabinoids | ||||||
| ∆9-THC | – | 1 | – | – | 4 | 1 |
| Carboxy-THC | 10 | 5 | 20 | 5 | – | – |
| 11-hydroxy-THC | – | 1 | – | – | – | – |
| DRE category; CNS stimulants | ||||||
| Methamphetamine | 20 | 20 | 200 | 50 | 20 | 20 |
| Amphetamine | 20 | 20 | 200 | 50 | 20 | 20 |
| MDMAa | – | 20 | – | 50 | 20 | 20 |
| MDAa | – | 20 | – | 50 | 20 | 20 |
| Cocaine | – | 10 | – | 20 | 15b | 8 |
| Benzoylecgonine | 50 | 50 | 150 | 50 | 15b | 8 |
| Cocaethylene | – | 10 | – | 20 | – | 8 |
| DRE category; CNS depressants | ||||||
| Carisoprodol | 1,000 | 1,000 | 1,000 | 1,000 | 500 | 500 |
| Meprobamatea | – | 500 | – | 500 | – | 500 |
| Zolpidem | 10 | 10 | 20 | 20 | 10 | 10 |
| Low-dose benzodiazepines | 10 | – | 50 | – | 5 | – |
| Alprazolam | – | 10 | – | 50 | – | 1 |
| Alpha-hydroxyalprazolam | – | – | – | 50 | – | – |
| Clonazepam | – | 10 | – | 50 | – | 1 |
| 7-Aminoclonazepam | – | 10 | – | 50 | – | 1 |
| Lorazepam | – | 10 | – | 50 | – | 1 |
| High-dose benzodiazepines | 50 | – | 100 | – | 5 | – |
| Diazepam | – | 20 | – | 50 | – | 1 |
| Nordiazepam | – | 20 | – | 50 | – | 1 |
| Oxazepam | – | 20 | – | 50 | – | 1 |
| Temazepam | – | 20 | – | 50 | – | 1 |
| DRE category; narcotic analgesics | ||||||
| Codeinea | – | 10 | – | 50 | 30 | 5 |
| 6-Acetylmorphine | – | 5 | – | 10 | – | 1 |
| Buprenorphine | 1 | 0.5 | 5 | 1 | 1 | 2 |
| Norbuprenorphine | – | 1 | – | 1 | – | – |
| Fentanyl | 1 | 0.5 | 1 | 1 | 1 | 0.5 |
| Hydrocodonea | – | 10 | – | 50 | 30 | 5 |
| Hydromorphonea | – | 5 | – | 50 | 30 | 5 |
| Methadone | 50 | 20 | 300 | 50 | 20 | 10 |
| Morphine | 10 | 10 | 200 | 50 | 30 | 5 |
| Oxycodonea | 10 | 10 | 100 | 50 | 30 | 5 |
| Oxymorphonea | – | 5 | – | 50 | 30 | 5 |
| Tramadol | 100 | 50 | 100 | 50 | 50 | 10 |
| O-Desmethyltramadol | – | 50 | – | 50 | – | – |
Must have ≥80% cross-reactivity if using immunoassay for blood and urine.
Screening for either benzoylecgonine or cocaine in oral fluid is acceptable.